Showing 521-530 of 3014 results for "".
How Much Are You Paying Your Advisor?
https://practicaldermatology.com/topics/practice-management/how-much-are-you-paying-your-advisor/20609/A guide to understanding advisor fees and other charges.Updates from ASDS 2017
https://practicaldermatology.com/series/dermwire-tv/updates-from-asds-2017/18411/From microneedling to skin redraping to body contouring, the Annual Meeting of the American Society for Dermatologic Surgery (ASDS) brings cosmetic and surgical dermatology into focus. With an emphasis on the state of the art in dermatologic procedures, the annual meeting of the ASDS gathered hundreIs Your SEO Strategy Outdated?
https://practicaldermatology.com/topics/practice-management/is-your-seo-strategy-outdated/20617/To optimize Google SEO, don't design your website for Google. An expert explains the paradox and other tips for SEO now.Essential Marketing Strategies
https://practicaldermatology.com/topics/practice-management/essential-marketing-strategies/18436/There are three essential tactics that set successful marketers apart from the rest. Risa Goldman Luksa of Goldman Marketing Group explains.Standing Apart: The Personal Touch
https://practicaldermatology.com/topics/practice-management/standing-apart-the-personal-touch/18437/Many dermatology practices exist in a crowded market place. How can they set themselves apart? Focus on the personal touch, says Gary Goldenberg, MD of Goldenberg Dermatology.Pearls for Treating Skin Cancer
https://practicaldermatology.com/topics/general-topics/pearls-for-treating-skin-cancer/18446/When should you treat basal cell carcinomas with adjuvant therapies before excising? Why is the number two important to remember when treating squamous cell carcinoma? Is Merkel cell carcinoma on the rise? Gary Goldenberg, MD answers these questions and offers an update on the newest therapies and bRe-introducing Ortho Dermatologics, Tremfya Approved, Obagi Acquired
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-re-introducing-ortho-dermatologics-tremfya-approved-obagi-acquired/18458/Valeant Pharmaceuticals is changing the name of its dermatology division to Ortho Dermatologics. In an exclusive interview with DermWireTV, Executive Vice President and dermatology industry veteran William Bill Humphries discusses the change. The FDA has approved Janssen Biotech's Tremfya (guselkumaRevance Data, AD Updates, FDA Actions
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-revance-data-ad-updates-fda-actions/18463/A US District Court judge blocks Stratus Pharmaceuticals of Miami and Sonar Products of Carlstadt, NJ from selling substandard dermatological products. Newly identified mutations in a gene called CARD11 may lead to atopic dermatitis. Surprising new evidence suggests atopic dermatitis is associated wWhy Your Dermatology Practice Should Be On Instagram
https://practicaldermatology.com/topics/practice-management/dermpracticeinstagram/18473/Instagram is different from most social networks. And it's growing quickly with skyrocketing mobile technology use. It's a marketing opportunity for dermatologists, especially those interested in cosmetic procedures. Learn how to use Instagram for your practice marketing and outreach in this Ekwa.coNeuromodulators in Medical Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neuromodulators-in-medical-dermatology/18520/Physicians are exploring the effects of botulinum toxins on several medical dermatology conditions. Erin Gilbert, MD talks to Joel Cohen, MD about her experience treating rosacea, and discusses the need for better randomized trials to explore treatment options.